Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
SABS, SABSW on Nasdaq
There are no Buy or Sell transactions made by Sessa Capital (Master), L.P. since 9/18/2023
Holdings reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Series A-2 Convertible Preferred Stock |
28.4K |
$28.4M |
$1,000.00 |
Nov 24, 2023 |
Direct |
Common Stock |
|
| Common Stock |
4.58M |
$4.03M |
$0.88 |
Nov 24, 2023 |
Direct |
|
|
| Tranche C Warrants |
52.1K |
|
|
Nov 10, 2023 |
Direct |
Series A-3 Convertible Preferred Stock |
|
| Tranche B Warrants |
20.8K |
|
|
Nov 10, 2023 |
Direct |
Series A-3 Convertible Preferred Stock |
|
| Series A-1 Convertible Preferred Stock |
0 |
|
$1,000.00 |
Nov 24, 2023 |
Direct |
Common Stock or Series A-2 Convertible Preferred Stock |
|
| Tranche A Warrants |
0 |
|
|
Nov 13, 2023 |
Direct |
Series A-1 or Series A-3 Convertible Preferred Stock |
|
Transactions reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.